Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy.

Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Louden C, Cornell JE, Thompson GR, Vallor AC, Wickes BL, Wiederhold NP, Redding SW, Patterson TF.

AIDS Res Treat. 2012;2012:262471. doi: 10.1155/2012/262471. Epub 2012 Aug 28.

2.

Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.

Kirkpatrick WR, Najvar LK, Vallor AC, Wiederhold NP, Bocanegra R, Pfeiffer J, Perkins K, Kugler AR, Sweeney TD, Patterson TF.

J Antimicrob Chemother. 2012 Apr;67(4):970-6. doi: 10.1093/jac/dkr567. Epub 2012 Jan 11.

PMID:
22240402
3.

Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient.

Westbrook SD, Wiederhold NP, Vallor AC, Kotara S, Bernardo S, Lee SA, Kirkpatrick WR, Toro JJ, Freytes C, Patterson TF, Redding SW.

Med Mycol. 2010 May;48(3):557-60. doi: 10.3109/13693780903213504.

4.

Strain-dependent variation in 18S ribosomal DNA Copy numbers in Aspergillus fumigatus.

Herrera ML, Vallor AC, Gelfond JA, Patterson TF, Wickes BL.

J Clin Microbiol. 2009 May;47(5):1325-32. doi: 10.1128/JCM.02073-08. Epub 2009 Mar 4.

5.

Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.

Thompson GR 3rd, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF.

Antimicrob Agents Chemother. 2009 Jan;53(1):309-11. doi: 10.1128/AAC.01216-08. Epub 2008 Oct 27.

6.

Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

Thompson GR 3rd, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS 2nd, Patterson TF.

Antimicrob Agents Chemother. 2008 Oct;52(10):3783-5. doi: 10.1128/AAC.00473-08. Epub 2008 Aug 1.

7.

Evaluation of Etest method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans.

Thompson GR 3rd, Fothergill AW, Wiederhold NP, Vallor AC, Wickes BL, Patterson TF.

Antimicrob Agents Chemother. 2008 Aug;52(8):2959-61. doi: 10.1128/AAC.00646-08. Epub 2008 Jun 16.

8.

Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.

Vallor AC, Kirkpatrick WR, Najvar LK, Bocanegra R, Kinney MC, Fothergill AW, Herrera ML, Wickes BL, Graybill JR, Patterson TF.

Antimicrob Agents Chemother. 2008 Jul;52(7):2593-8. doi: 10.1128/AAC.00276-08. Epub 2008 May 12.

9.

Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.

Wiederhold NP, Najvar LK, Vallor AC, Kirkpatrick WR, Bocanegra R, Molina D, Olivo M, Graybill JR, Patterson TF.

Antimicrob Agents Chemother. 2008 Mar;52(3):1176-8. Epub 2007 Dec 26.

10.

Standardization of an experimental murine model of invasive pulmonary aspergillosis.

Sheppard DC, Graybill JR, Najvar LK, Chiang LY, Doedt T, Kirkpatrick WR, Bocanegra R, Vallor AC, Patterson TF, Filler SG.

Antimicrob Agents Chemother. 2006 Oct;50(10):3501-3.

11.

Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.

Kirkpatrick WR, Vallor AC, McAtee RK, Ryder NS, Fothergill AW, Rinaldi MG, Patterson TF.

Antimicrob Agents Chemother. 2005 Nov;49(11):4751-3.

12.

Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production.

Vallor AC, Antonio MA, Hawes SE, Hillier SL.

J Infect Dis. 2001 Dec 1;184(11):1431-6. Epub 2001 Oct 30.

PMID:
11709785

Supplemental Content

Loading ...
Support Center